|Bid||0.8900 x 800|
|Ask||0.9240 x 1300|
|Day's range||0.8900 - 0.9526|
|52-week range||0.8900 - 14.6000|
|Beta (5Y monthly)||0.01|
|PE ratio (TTM)||N/A|
|Earnings date||28 Nov 2022 - 02 Dec 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.71|
Genetron Holdings Limited ( NASDAQ:GTH ) shareholders will doubtless be very grateful to see the share price up 36% in...
The big shareholder groups in Genetron Holdings Limited ( NASDAQ:GTH ) have power over the company. Institutions will...
Genetron Holdings (NASDAQ: GTH), a Chinese oncology testing company, briefly climbed to a high of $11.11 a share on Tuesday morning, up more than 9.3% over its closing price of $9.60 a share on Monday. Genetron reported its third-quarter earnings before the market opened on Tuesday. It also said that its gross margins had grown from 62% to 69%.